Literature DB >> 12594648

Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa.

Charles B Holmes1, Elena Losina, Rochelle P Walensky, Yazdan Yazdanpanah, Kenneth A Freedberg.   

Abstract

Understanding the natural history of human immunodeficiency virus type 1 (HIV-1) and opportunistic infections in sub-Saharan Africa is necessary to optimize strategies for the prophylaxis and treatment of opportunistic infections and to understand the likely impact of antiretroviral therapy. We undertook a systematic review of the literature on HIV-1 infection in sub-Saharan Africa to assess data from recent cohorts and selected cross-sectional studies to delineate rates of opportunistic infections, associated CD4 cell counts, and associated mortality. We searched the MEDLINE database and the Cochrane Database of Systematic Reviews and Cochrane Clinical Trials Register for English-language literature published from 1990 through April 2002. Tuberculosis, bacterial infections, and malaria were identified as the leading causes of HIV-related morbidity across sub-Saharan Africa. Of the few studies that reported CD4 cell counts, the range of cell counts at the time of diagnosis of opportunistic infections was wide. Policies regarding the type and timing of opportunistic infection prophylaxis may be region specific and urgently require further study.

Entities:  

Mesh:

Year:  2003        PMID: 12594648     DOI: 10.1086/367655

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  53 in total

1.  A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.

Authors:  D Guwatudde; S M Debanne; M Diaz; C King; C C Whalen
Journal:  Prev Med       Date:  2004-11       Impact factor: 4.018

2.  Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis.

Authors:  Krishna K Singh; Yuxin Dong; John T Belisle; Jeffrey Harder; Vijay K Arora; Suman Laal
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

3.  Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans.

Authors:  Xiaorong Lin; Kirsten Nielsen; Sweta Patel; Joseph Heitman
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

4.  HIV infection mimicking autoimmune disorder.

Authors:  Jhuma Sankar; Dinesh Raj; Jeeva Sankar; Pradeep K Sharma; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

5.  Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania.

Authors:  Molly F Franke; Donna Spiegelman; Amara Ezeamama; Said Aboud; Gernard I Msamanga; Saurabh Mehta; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 6.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

7.  Evolution of Cryptococcal Antigen Testing: What is new?

Authors:  Elizabeth Nalintya; Reuben Kiggundu; David Meya
Journal:  Curr Fungal Infect Rep       Date:  2016-04-12

8.  Surviving Sepsis in High HIV Prevalence Settings.

Authors:  Ben Andrews
Journal:  Med J Zambia       Date:  2010

9.  Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011.

Authors:  Doudou Sow; Roger Clément Tine; Khadime Sylla; Mansata Djiba; Cheikh Tidiane Ndour; Thérèse Dieng; Jean Louis Ndiaye; Babacar Faye; Daouda Ndiaye; Oumar Gaye; Yémou Dieng
Journal:  Mycopathologia       Date:  2013-10-25       Impact factor: 2.574

10.  The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.

Authors:  Brian K Kigozi; Samwel Sumba; Peter Mudyope; Betty Namuddu; Joan Kalyango; Charles Karamagi; Mathew Odere; Elly Katabira; Peter Mugyenyi; Francis Ssali
Journal:  AIDS Res Ther       Date:  2009-07-24       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.